These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2569812)

  • 1. Effects of norakin on respiratory syncytial virus in tissue culture and in mice.
    Mentel R; Schroeder C; Döhner L
    Acta Virol; 1989 Mar; 33(2):162-6. PubMed ID: 2569812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.
    Lupfer C; Patton KM; Pastey MK
    Toxicology; 2010 Jan; 268(1-2):25-30. PubMed ID: 19931343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DSCG reduces RSV-induced illness in RSV-infected mice.
    Hashimoto K; Mori S; Hashimoto Y; Kaneko H; Ishibashi K; Ishioka K; Kawasaki Y; Peebles RS; Munakata M; Hosoya M; Suzutani T
    J Med Virol; 2009 Feb; 81(2):354-61. PubMed ID: 19107959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
    Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
    Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of Alternanthera philoxeroides Griseb against respiratory syncytial virus infection in mice].
    Jiang WL; Yang ZQ; Chen W; Xiao H; Luo XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):62-4. PubMed ID: 17259148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro inhibitory mechanism of respiratory syncytial virus with solution prescription of zhidanhuayu].
    Liu YH; Hou AC; Zhao GC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):486-7. PubMed ID: 19544654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.
    Zhang W; Tripp RA
    J Virol; 2008 Dec; 82(24):12221-31. PubMed ID: 18818323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice.
    Zhou J; Yang XQ; Xie YY; Zhao XD; Jiang LP; Wang LJ; Cui YX
    Virus Res; 2007 Dec; 130(1-2):241-8. PubMed ID: 17804108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
    Teng MN; Whitehead SS; Collins PL
    Virology; 2001 Oct; 289(2):283-96. PubMed ID: 11689051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
    Bolger G; Lapeyre N; Dansereau N; Lagacé L; Berry G; Klosowski K; Mewhort T; Liuzzi M
    Can J Physiol Pharmacol; 2005 Feb; 83(2):198-213. PubMed ID: 15791294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by Norakin (triperiden) of Sindbis virus infection in mice.
    Veckenstedt A; Güttner J; Schroeder C
    Acta Virol; 1985 May; 29(3):209-15. PubMed ID: 2864821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary respiratory syncytial virus infection in mice].
    Zou Y; Huang H; Xu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):484-6. PubMed ID: 11718040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action.
    Sudo K; Miyazaki Y; Kojima N; Kobayashi M; Suzuki H; Shintani M; Shimizu Y
    Antiviral Res; 2005 Feb; 65(2):125-31. PubMed ID: 15708639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro.
    Franke-Ullmann G; Pförtner C; Walter P; Steinmüller C; Lohmann-Matthes ML; Kobzik L; Freihorst J
    J Immunol; 1995 Jan; 154(1):268-80. PubMed ID: 7995946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals.
    Ojwang JO; Wang YH; Wyde PR; Fischer NH; Schuehly W; Appleman JR; Hinds S; Shimasaki CD
    Antiviral Res; 2005 Dec; 68(3):163-72. PubMed ID: 16280176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.
    Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS
    Virol J; 2005 Feb; 2():3. PubMed ID: 15701174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model.
    Ottolini MG; Curtis SR; Mathews A; Ottolini SR; Prince GA
    Bone Marrow Transplant; 2002 Jan; 29(2):117-20. PubMed ID: 11850705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.
    Miller AL; Bowlin TL; Lukacs NW
    J Infect Dis; 2004 Apr; 189(8):1419-30. PubMed ID: 15073679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene.
    Zhang W; Yang H; Kong X; Mohapatra S; San Juan-Vergara H; Hellermann G; Behera S; Singam R; Lockey RF; Mohapatra SS
    Nat Med; 2005 Jan; 11(1):56-62. PubMed ID: 15619625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.